Related Experiment Videos
Endothelin-1 and Paget's bone disease: is there a link?
R Tarquini1, F Perfetto, B Tarquini
1Institute of Clinica Medica IV, Unit of Internal Medicine, University of Florence, Italy.
Calcified Tissue International
|August 1, 1998
Summary
Elevated circulating endothelin-1 (ET-1) levels were observed in patients with active Paget's bone disease, suggesting a role for this peptide in bone metabolism and potentially serving as a marker for disease activity.
Area of Science:
- Endocrinology
- Bone Biology
- Cell Signaling
Background:
- Endothelial cells in bone marrow interact with bone cells, suggesting endothelin-1 (ET-1) involvement in bone metabolism.
- ET-1 influences osteoclast differentiation and resorption, and osteoblast proliferation.
- Paget's bone disease is characterized by accelerated bone turnover.
Purpose of the Study:
- To investigate circulating endothelin-1 (ET-1) levels in patients with active Paget's bone disease.
- To explore the potential role of ET-1 in the pathophysiology of Paget's bone disease.
Main Methods:
- Plasma ET-1 levels were measured using RIA kits.
- 11 patients with active Paget's bone disease and 10 healthy controls were enrolled.
- Circulating ET-1 levels were correlated with serum alkaline phosphatase (ALP) and urinary hydroxyproline.
Main Results:
- Patients with Paget's bone disease exhibited significantly higher plasma ET-1 levels compared to controls (P < 0.01).
- A positive correlation was found between ET-1 levels and serum alkaline phosphatase (ALP) (r = 0.63; P = 0.038).
- No significant correlation was observed between ET-1 levels and urinary hydroxyproline.
Conclusions:
- The elevated ET-1 levels suggest a pathophysiological role for endothelin-1 in Paget's bone disease.
- Circulating ET-1 may serve as a novel marker for assessing Paget's bone disease activity.